Welcome to our dedicated page for National Research Corporation news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Research Corporation stock.
National Research Corporation Common Stock (Delaware) (symbol: NRC) is dedicated to enhancing the experiences of patients, residents, and healthcare providers for over 35 years. Operating primarily in the United States and Canada, NRC Health provides analytics and insights that help healthcare organizations measure and improve patient and employee experiences, fostering greater engagement and loyalty.
NRC Health's offerings include a wide range of solutions that deliver value to its clients by enabling a deeper understanding of the individuals they serve. This holistic approach includes proprietary methods and tools that aid healthcare systems in designing experiences that build trust and inspire loyalty. These solutions are critical for healthcare providers, payers, and other organizations aiming to improve care delivery and patient outcomes.
In recent developments, NRC Health has partnered with LifeBridge Health, one of Maryland’s largest health systems, to implement the Human Understanding® program. This partnership, highlighted by NRC Health’s comprehensive data-driven insights and personalized healthcare solutions, aims to enhance patient care and satisfaction through innovative, human-centered approaches. The collaboration also involves administering the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey to ensure consistent quality measures.
Financially, NRC Health remains robust, drawing significant revenue from its United States operations. Its focused market research, patient-centered initiatives, and consumer preference data have earned NRC Health a top ranking for Patient Experience Improvement in the 2023 Best in KLAS report.
For more information about NRC Health, their services, or recent updates, visit www.nrchealth.com. You can also contact them at 800-388-4264 or via email at info@nrchealth.com.
NRC Health reported its third-quarter 2022 results, revealing revenue of $37.7 million, slightly down from $37.8 million in Q3 2021. The company’s net income declined to $8.3 million from $9.7 million year-over-year, leading to a decrease in diluted earnings per share, which fell to $0.33 from $0.38. Despite revenue growth from core offerings, the overall revenue was flat due to the phasing out of Canadian operations and a decline in non-core offerings. Increased operating expenses were attributed to investments in innovation and marketing. Dividends paid amounted to $5.9 million.
NRC Health's recent study reveals a significant disparity in trust levels between local healthcare providers and government entities during the COVID-19 pandemic. The research indicates that patients' language preferences notably influence their trust in healthcare providers, with English speakers 29% more likely to express strong trust. Additionally, trust in local healthcare systems rose from 20.7% to 35.8% from April 2020 to August 2022, while federal trust waned. Notably, trust levels are politically mixed across U.S. counties, challenging the narrative that political affiliation heavily influences provider trust.
On October 19, 2022, National Research Corporation (NASDAQ: NRC) announced an online web simulcast for its third quarter earnings conference call, scheduled for November 2, 2022, at 11:00 a.m. ET. The earnings results will be released after market close on November 1, 2022. A live audio webcast will be accessible via their website, with a replay available for 30 days after the event. NRC has a longstanding commitment to enhancing healthcare experiences through its proprietary methods and holistic approach.
NRC Health, a leader in personalized healthcare solutions, has announced its sponsorship of the Creative Learning Event Series organized by the Society for Participatory Medicine (SPM). This year-long initiative aims to enhance patient-provider relationships and promote equity in healthcare. The first event will be held on October 20, 2022, in Boston, focusing on access to care in underserved communities. NRC Health's support aligns with its mission of achieving Human Understanding, emphasizing collaboration among patients and healthcare professionals.
NRC Health announced a quarterly cash dividend of $0.24 per share, payable on October 14, 2022, to shareholders on record by September 30, 2022. This decision reflects NRC Health's ongoing commitment to returning value to its investors. With over 40 years of experience, NRC Health focuses on enhancing healthcare experiences and building trust within organizations through innovative methods and skilled associates.
NRC Health announced the winners of its 2022 Consumer Loyalty Awards and Excellence in Patient Experience Awards. This year, top hospitals were acknowledged for exceptional patient experiences amidst ongoing healthcare challenges post-pandemic. The Consumer Loyalty Awards spotlighted the top 100 healthcare facilities focusing on cultivating long-lasting loyalty, with ten facilities designated as Best-In-Class. The Excellence in Patient Experience Awards recognized hospitals for their commitment to improving patient care, based on Net Promoter Scores from patient surveys.
NRC Health announced its new role as a Diamond Supporting Partner with The Beryl Institute, emphasizing a commitment to enhancing patient experience through collaboration. This partnership aims to provide resources and opportunities for healthcare organizations to better serve patients. Helen Hrdy, Chief Growth Officer, underscored the critical need for patient-centered care. NRC Health has actively supported The Beryl Institute through past events and will now contribute to expanding the community's content and access to resources for members globally.
On August 2, 2022, National Research Corporation (NASDAQ:NRC) reported a 2% increase in Q2 2022 revenue, totaling $37.3 million, compared to $36.4 million in Q2 2021. However, operating income fell by 6% to $11.5 million, with net income decreasing to $8.3 million from $8.9 million. Diluted earnings per share also declined to $0.33. The company secured its first contract for the Human Understanding Program with Novant Health and continues to prioritize organic growth, despite challenges from discontinued offerings impacting revenue growth.
National Research Corporation (NASDAQ:NRC) will host a web simulcast of its Q2 2022 earnings conference call on August 3, 2022, following the market close on August 2, 2022, when the earnings results will be released. The live broadcast starts at 11:00 a.m. ET and will be available for replay for 30 days. NRC has over 40 years of experience in enhancing healthcare through Human Understanding, helping organizations improve customer experiences and trust.
FAQ
What is the current stock price of National Research Corporation (NRC)?
What is the market cap of National Research Corporation (NRC)?
What services does NRC Health provide?
Where does NRC Health operate?
What is the Human Understanding® program?
Who are NRC Health's recent partners?
What is the CAHPS survey?
How long has NRC Health been in operation?
What distinguishes NRC Health in the market?
How can I contact NRC Health?
What type of organizations benefit from NRC Health's services?
How does NRC Health support healthcare organizations?
